Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection - The American Journal of Medicine
Glenmark Launches Favipiravir For Treatment Of Mild To Moderate Covid-19 Patients
AA Medical Products Ltd.
Influenza virus polymerase inhibitors in clinical development. - Abstract - Europe PMC
Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques | PLOS Medicine
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis | Virology Journal | Full Text
RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study | SpringerLink
Microorganisms | Free Full-Text | Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome - eBioMedicine
Fabiflu Full Prescribing Information, Dosage & Side Effects | MIMS Thailand
Frontiers | Favipiravir Effectiveness and Safety in Hospitalized Moderate-Severe COVID-19 Patients: Observational Prospective Multicenter Investigation in Saudi Arabia
Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis | BMC Infectious Diseases | Full Text
Viruses | Free Full-Text | Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial - ScienceDirect
High doses of favipiravir combat SARS-CoV-2 in hamsters
Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial — PRINCIPLE Trial
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? | SpringerLink
Favipiravir: A new and emerging antiviral option in COVID-19 - ScienceDirect
Favipiravir and Remdesivir Appear to be Relatively Unencumbered with Drug-Drug Interactions - Anesthesia Patient Safety Foundation
تويتر \ H & FW Dept Odisha على تويتر: "Follow the advisory to know about # Favipiravir treatment during home isolation. #COVID19 positive patients with mild symptoms remaining under home isolation can recover
Advances in Clinical and Experimental Medicine
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections - ScienceDirect
Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19
Untitled
